Convalescent plasma clinical trial ramps up

September 7, 2020

On the heels of FDA authorization of convalescent plasma as a treatment for COVID-19, UNC researchers are conducting a clinical trial to determine the safety and efficacy of plasma that includes a higher amount of neutralizing antibodies against SARS-CoV-2. The new Coronavirus-inactivating Plasma (CoVIP) research clinical trial is designed to determine the safety and efficacy … Continued

Wohl launches clinical trial, one of 25 sites nationally testing COVID-19 treatments

September 1, 2020

  UNC Institute for Global Health and Infectious Diseases researchers have begun phase 2 and phase 3 evaluations of promising treatments for COVID-19. The UNC School of Medicine joins more than 25 initial sites participating in the clinical trials through ACTIV-2, a public-private partnership sponsored by the NIH’s National Institute of Allergy and Infectious Diseases … Continued

UNC-led consortium to study HIV-related cancers in sub-Saharan Africa

August 24, 2020

A team of UNC researchers are partnering with colleagues at four institutions in Africa to study HIV-associated malignancies. With a five-year, $6 million grant from the NIH’s National Cancer Institute, the research consortium will look at screening and diagnosing innovations for three cancers common to people with HIV: Kaposi sarcoma, cervical cancer and lymphoma. Leading … Continued

In memoriam: UNC Project-Malawi colleagues pay tribute to Dr. Peter Kazembe

August 20, 2020

Our dear friend, Dr. Peter Kazembe, a Malawian colleague, pediatrician and adjunct professor of medicine with the University of North Carolina’s Institute for Global Health and Infection Diseases, died on August 11, 2020 at the age of 65 while receiving treatment for cancer in South Africa. He is survived by his wife, Hilda, and three … Continued

Remembering Steve Meshnick: Colleague, mentor and friend

August 6, 2020

“There are few people like him,” as a long-term collaborator and friend said. “Steve was so humble and generous that I don’t think he really understood the impact he had on the people around him. He profoundly changed for the better the lives of so many people he worked with and trained, without ever asking … Continued

ID faculty organize, conduct COVID-19 testing in hard-hit Lee County, NC

July 29, 2020

  It’s hot (especially wearing full PPE), it’s tedious, and it’s critical. A volunteer team of UNC infectious diseases faculty members along with UNC hospitalists has been conducting drive-up testing for COVID-19 in Sanford, NC, about 35 miles south of Chapel Hill, twice a month since June, seeing roughly 1,000 local residents so far this … Continued

Welcome 2020-2021 Infectious Diseases fellows

July 29, 2020

Five fellows joined UNC’s Division of Infectious Diseases in July for the 2020-2021 academic year. The trainees gain clinical and research experience along with career guidance and mentoring by the division’s faculty members. One of the fellows, Daphne-Dominique Henson Villanueva, MD, will be doing advanced training in immunocompromised host infectious diseases and antimicrobial stewardship.

Gay leading phase 3 trial of COVID-19 vaccine

July 28, 2020

In February 2020, as bits of data about the SARS-CoV-2 virus started to emerge, Cindy Gay, MD, MPH, and UNC infectious diseases colleagues began meeting to formulate a local response to the virus. They’ve met weekly ever since, resorting to Zoom calls once the university sent employees home in March. They’ve shared data, compared notes … Continued

Suzanne Maman, PhD, named associate dean for global health

July 28, 2020

Suzanne Maman, PhD, professor of health behavior at the Gillings School of Global Public Health, has been appointed associate dean for global health, effective September 1, 2020. The associate dean for global health is the School’s chief global leader and liaison, responsible for evolving global strategy and global health initiatives. Maman succeeds Margaret (Peggy) Bentley, … Continued

NIH awards Cohen, FHI $9.2 million for development of COVID prevention studies

July 21, 2020

The National Institutes of Health has awarded Myron Cohen, MD, director of UNC’s Institute for Global Health and Infectious Diseases, and FHI 360 $9.2 million to support research through the new COVID Prevention Network (CoVPN). The National Institute of Allergy and Infectious Diseases at the National Institutes of Health has formed the network to better … Continued

Institute’s Leadership Team expands with four new members

July 9, 2020

Four appointments in 2020 have expanded the Institute for Global Health and Infectious Diseases’ Leadership Team. The team’s members bring unique expertise, experience, and perspectives from across the University of North Carolina’s health science schools to set strategy and lead the growth of one of UNC’s preeminent research centers. “Since our founding in 2007, the … Continued

Institute research sampling, 2018-2020

July 7, 2020

By the spring of 2020, the urgency of the COVID-19 pandemic caused many researchers affiliated with UNC’s Institute for Global Health and Infectious Diseases to pivot their studies to focus on testing, treatment and prevention of the SARS-CoV-2 virus. Here, a look at some of the projects underway in the last two years.   Development … Continued

Cohen, Fischer, and Pettifor update Board of Trustees on COVID-19 efforts

June 7, 2020

  Three Institute for Global Health and Infectious Diseases representatives joined the May 21 UNC Board of Trustees meeting to talk about COVID-19 and the university’s response to the pandemic. Institute Director Myron Cohen, MD, talked about how so many of our researchers have pivoted their work to COVID, working on the development of vaccine … Continued

Parr, medical students conduct first study of tocilizumab in treating COVID-19

May 19, 2020

  In the first COVID-19 case series of tocilizumab in the United States, UNC-Chapel Hill researchers report sobering results. They say the drug should be used judiciously until randomized clinical trials determine tocilizumab’s true efficacy. Meanwhile, medical students sidelined from clinical rotations by the virus conducted the research with lightning speed, all virtually. In the … Continued

Study finds three strains of resistant bacteria, identifying greater diversity

May 14, 2020

    A new study by the Multi-Drug-Resistant Organism Network of the Antibacterial Resistance Leadership Group (ARLG) has found that strains of carbapenem-resistant enterobacterales (CRE), a major threat to vulnerable patient populations, are more diverse than previously thought. The MDRO Network is led by UNC Infectious Diseases investigator David van Duin, MD, PhD. Analyzing patient … Continued

Comprehensive primary care clinic proposed for people living with HIV

May 6, 2020

A novel collaboration between UNC’s Department of Medicine and Division of Infectious Diseases includes creating a multidisciplinary primary care clinic to serve people living with HIV. The new model lays the groundwork for multidisciplinary care in advance of the move to Eastowne. Led by Claire Farel MD, MPH, medical director of the UNC Infectious Diseases Clinic, Amy Durr, … Continued

Cohen, Fowler inducted into UNC’s Order of the Golden Fleece

May 6, 2020

Myron Cohen, MD, Yeargan-Bate Distinguished Professor of medicine, microbiology, and immunology and epidemiology and director of the Institute for Global Health and Infectious Diseases, and Wesley Fowler, MD, associate dean for medical alumni affairs and professor of obstetrics and gynecology,and have been inducted into the Order of the Golden Fleece, UNC’s oldest and most prestigious … Continued

Schranz receives NIH grant to study patient care for drug-use related heart infections

May 6, 2020

Asher Schranz, MD, MPH, assistant professor of medicine in the division of infectious diseases, has received a grant from the NIH National Institute on Drug Abuse for the project “Drug-use associated infective endocarditis: Post-hospitalization outcomes and patient treatment preferences.” Schranz’s research is broadly focused on the intersection of infectious diseases and substance use disorders. He … Continued